Abstract Number: 0610 • ACR Convergence 2026
What People with Lupus Need to Make Treatment Decisions: Focus Group Findings to Inform a Shared Decision-Making Tool
Background/Purpose: Shared decision-making (SDM) is a collaborative process integrating clinical evidence with patient values and circumstances. Despite SDM being a facilitator of high-quality, equitable care,…Abstract Number: 0770 • ACR Convergence 2026
Language-Based Disparities and Delay to Diagnosis and Treatment of Axial Spondyloarthritis
Background/Purpose: Axial spondyloarthritis (axSpA) is associated with an average diagnostic delay of 5 to 10 years [1], which has been linked to poorer functional outcomes,…Abstract Number: 0772 • ACR Convergence 2026
Medication Adherence in an Urban Safety-Net Rheumatology Clinic: Associations with Social Determinants and Clinical Factors
Background/Purpose: Medication adherence is essential for effective management of chronic rheumatic diseases (RMDs). Patient and disease characteristics, along with social determinants of health (SDOH), can…Abstract Number: 0908 • ACR Convergence 2026
Reframing Strength: Superwoman Schema and Self-Management in Black Women with Systemic Lupus Erythematosus
Background/Purpose: Black women bear a disproportionate burden of systemic lupus erythematosus (SLE) inequities including poorer quality of life and cardiovascular health. Sociobehavioral mechanisms underlying these…Abstract Number: 1539 • ACR Convergence 2026
Patient Perspectives on Allogeneic CAR T Cell Therapy in Systemic Lupus Erythematosus: Findings from a Focus Group Study (Part 3)
Background/Purpose: Systemic lupus erythematosus (SLE) disproportionately affects racial and ethnic minoritized populations who also remain underrepresented in SLE clinical trials. Patient-centered evidence is needed to…Abstract Number: 1701 • ACR Convergence 2026
Association Between Caregiver-Reported Social Risk and Clinic Adherence Rates in Pediatric Rheumatology
Background/Purpose: BackgroundSocial determinants of health (SDoH) influence outcomes in pediatric chronic disease, yet their relationship to clinic adherence among pediatric rheumatology patients is not well…Abstract Number: 1710 • ACR Convergence 2026
Persisting Racial and Ethnic Disparities in Systemic Lupus Erythematosus Hospitalizations in the United States
Background/Purpose: To assess the age-sex-adjusted rate of primary SLE hospitalizations by race/ethnicity and determine if there are racial/ethnic disparities in primary SLE hospitalizations in the…Abstract Number: 1711 • ACR Convergence 2026
Racial and Social Disparities in Inpatient Outcomes Among Adults with SLE: A Nationwide Analysis, 2016-2023
Background/Purpose: Underrepresented individuals with systemic lupus erythematosus (SLE) have a higher likelihood of a more severe disease course, thereby increasing the risk of mortality and…Abstract Number: 1735 • ACR Convergence 2026
A Comparison of Healthcare Resource Utilization Amongst African American Women with and without Systemic Lupus Erythematosus (SLE)
Olivia Metcalf1, Bethany Wolf2, Taylor White1, Lori Ann Ueberroth3, L Quinnette King3, Charmayne Dunlop-Thomas4, Lee Moultrie5, Marquetta Goodwine6, Edith Williams7, S. Sam Lim8, Carl Langefeld9, Diane Kamen10 and Paula Ramos1 Affiliations: 1Emory University School of Medicine, Atlanta, GA, 2Medical University of South Carolina, Charleston, SC, 3Medical University of South Carolina, Charleston, 4Emory University, Atlanta, GA, 5Lee H Moultrie & Associates, North Charleston, 6Gullah/Geechee Nation, St Helena Island, SC, 7University of Rochester Medical Center, Rochester, NY, 8Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 9Wake Forest University School of Medicine, Winston-Salem, NC, 10Medical University of South Carolina, Johns Island, SC
Background/Purpose: Systemic lupus erythematosus (SLE) disproportionately affects African American women and is associated with increased healthcare resource utilization (HRU). Insurance coverage may influence access to…Abstract Number: 1769 • ACR Convergence 2026
Understanding the Impact of Systemic Lupus Erythematosus on Work Productivity and Daily Activity Among African American Women
Background/Purpose: Systemic lupus erythematosus (SLE) causes a range of fluctuating symptoms affecting individuals and their ability to work. African American women experience a disproportionate burden…Abstract Number: 1770 • ACR Convergence 2026
A Hard Pill to Swallow: A Lupus Nephritis Medication Adherence Pilot Using Proactive Screening and Clinical Pharmacy Intervention
Background/Purpose: Medication non-adherence in lupus nephritis (LN) is associated with renal flare, disease progression, and increased hospitalization. Clinical pharmacy practitioners (CPPs) represent an emerging direct…Abstract Number: 2495 • ACR Convergence 2026
Electronic Health Record Algorithms Have Lower Predictive Value in Black Juvenile Idiopathic Arthritis Patients and are More Affected by Exclusion criteria
Background/Purpose: Juvenile idiopathic arthritis (JIA) is an autoimmune arthritis with multiple subtypes and clinical heterogeneity, making it difficult to diagnose and treat. Black JIA patients have higher disease…Abstract Number: 2501 • ACR Convergence 2026
Mapping Disparities in Juvenile Dermatomyositis: A Retrospective Geospatial Study of Non-medical Drivers, Disease Presentation, and Clinical Course
Background/Purpose: Prior studies suggest race, socioeconomic disadvantage, and delayed access to rheumatology care contribute to worse outcomes in juvenile dermatomyositis (JDM). Individual and neighborhood factors'…Abstract Number: 2541 • ACR Convergence 2026
Preliminary Results of a Patient-Informed, Culturally Tailored Support and Education Pilot Program for Latinx RA Patients
Background/Purpose: Significant disparities in outcomes among Latinx patients with rheumatoid arthritis (LRA) have been well documented, including pain, fatigue, disability, and depression. Studies attribute poorer outcomes to barriers such as limited…Abstract Number: 0140 • ACR Convergence 2026
Urinary DNA Methylation Distinguishes Active Lupus Nephritis from APOL1-Associated Kidney Disease in Systemic Lupus Erythematosus
Background/Purpose: Progressive LN is a leading cause of end-stage kidney disease (ESKD) and a major driver of morbidity and mortality in SLE. Two coding variants…
ACR Meeting Abstracts